Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Mar 2007
- 421-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0923-7534
10.1093/annonc/mdl175 doi
Antibodies, Monoclonal--pharmacology Antineoplastic Agents--pharmacology Carcinoma, Squamous Cell--drug therapy ErbB Receptors--antagonists & inhibitors Head and Neck Neoplasms--drug therapy Humans Protein Kinase Inhibitors--pharmacology Receptor Protein-Tyrosine Kinases--antagonists & inhibitors Receptor, IGF Type 1--antagonists & inhibitors Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors Signal Transduction--drug effects